Enara Bio

OverviewSuggest Edit

Enara Bio (formerly known as Ervaxx) is a biotech company specializing in the use of Dark Antigens to deliver vaccines and other immunotherapies for treating and preventing cancer. It develops EDAPT, a differentiated technology platform designed to explore the new and expanding Dark Antigen repertoire and to identify and assess its tumor specificity and immunogenic potential to combat cancers.

TypePrivate
Founded2016
HQOxford, GB
Websiteenarabio.com

Latest Updates

Employees (est.) (Sept 2021)42(+8%)
Cybersecurity ratingAMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Enara Bio

Kevin Pojasek

Kevin Pojasek

President and Chief Executive Officer, Director
Ray Jupp

Ray Jupp

Chief Scientific Officer
Jonathon Dines

Jonathon Dines

Finance Director
Mark Creighton-Gutteridge

Mark Creighton-Gutteridge

Vice President, Head of Research
David Watson

David Watson

Chief Operating Officer
Joseph Dukes

Joseph Dukes

Vice President, Translational Science
Show more

Enara Bio Office Locations

Enara Bio has offices in Oxford and London
Oxford, GB (HQ)
Magdalen Centre, Robert Robinson Ave, Littlemore
London, GB
55-56 Russell Square, Holborn
London, GB
71 Kingsway, Holborn
Oxford, GB
Headington
Show all (4)

Enara Bio Financials and Metrics

Summary Metrics

Founding Date

2016

Enara Bio total Funding

$17.5 m

Enara Bio latest funding size

$17.5 m

Time since last funding

2 years ago

Enara Bio investors

Enara Bio's latest funding round in November 2019 was reported to be $17.5 m. In total, Enara Bio has raised $17.5 m
Show all financial metrics

Enara Bio Cybersecurity Score

Cybersecurity ratingPremium dataset

A

94/100

SecurityScorecard logo

Enara Bio Online and Social Media Presence

Embed Graph

Enara Bio News and Updates

Enara Bio announces the appointment of highly experienced biotech executive Dr. Robert Ang to its Board of Directors

OXFORD, England, Sept. 28, 2021 /PRNewswire/ -- Enara Bio, a biotechnology company advancing novel T-cell receptor (TCR) directed immunotherapies against unconventional, shared, cancer-specific antigens, announces the appointment of Dr. Robert Ang to the Company's Board of Directors as an...

Enara Bio Frequently Asked Questions

  • When was Enara Bio founded?

    Enara Bio was founded in 2016.

  • Who are Enara Bio key executives?

    Enara Bio's key executives are Kevin Pojasek, Ray Jupp and Jonathon Dines.

  • How many employees does Enara Bio have?

    Enara Bio has 46 employees.

  • Who are Enara Bio competitors?

    Competitors of Enara Bio include Immunovo, Coherus BioSciences and Cleveland BioLabs.

  • Where is Enara Bio headquarters?

    Enara Bio headquarters is located at Magdalen Centre, Robert Robinson Ave, Littlemore, Oxford.

  • Where are Enara Bio offices?

    Enara Bio has offices in Oxford and London.

  • How many offices does Enara Bio have?

    Enara Bio has 4 offices.